Abstract 3488: External validation of lysyl oxidase-like 2 (LOXL2) as a novel prognostic marker for gastro-entero-pancreatic neuroendocrine tumors (GEP-NET)Jorge Barriuso, Marta Mendiola, Laura Guerra et al.|Cancer Research|2016Cited by 0
Study of the gastroenteropancreatic neuroendocrine tumor (gep-net) microenvironment beyond angiogenesis: The role of lysyl oxidase-like 2 (LOXL2).Jorge Barriuso, Marta Mendiola, Elsa Bernal et al.|Journal of Clinical Oncology|2014Cited by 0